Congestive heart failure disease management program: 1-Year population experience from a tertiary center heart failure registry in Saudi Arabia

Salem, Khal; Fallata, Dania; Elsebaie, Maha Hamed; Montasser, Ahmad; ElGedamy, K.; Elkhateeb, Osama

doi:10.1016/j.jsha.2016.07.002

Cited by 5 publications

(6 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An analysis of 43,143 patients treated at 171 centers revealed that the hospitals with high risk-adjusted 30-day readmission rate also had higher 1-year all cause readmission rate (59.1% vs. 54.7%, respectively; p = 0.01) [24]. The HFDMP group in our study had a lower 1-year readmission rate (29.67%) compared to HF patients treated with standard care as reported in the TSOC-HFrEF registry (38.5%) [2] and in HF registries in other countries (e.g., 30.1% in IN-HF outcome registry in India [25] and 36% in registry in Saudi Arabia [26]). In comparison, the EHFS-2 registry in Europe reveals a 1-year morality rate of 21.9% for patients hospitalized with acute HF [27], and the IN-HF registry in India reveals a 1-year morality rate of 24.4% [25].…”

Section: Discussionmentioning

confidence: 56%

Impact of multi-disciplinary treatment strategy on systolic heart failure outcome

Chen

Fang

Wang

et al. 2019

BMC Cardiovasc Disord

View full text Add to dashboard Cite

Background Patients with reduced ejection fraction have high rates of mortality and readmission after hospitalization for heart failure. In Taiwan, heart failure disease management programs (HFDMPs) have proven effective for reducing readmissions for decompensated heart failure or other cardiovascular causes by up to 30%. However, the benefits of HFDMP in different populations of heart failure patients is unknown. Method This observational cohort study compared mortality and readmission in heart failure patients who participated in an HFDMP (HFDMP group) and heart failure patients who received standard care (non-HFDMP group) over a 1-year follow-up period after discharge (December 2014 retrospectively registered). The components of the intervention program included a patient education program delivered by the lead nurse of the HFDMP; a cardiac rehabilitation program provided by a physical therapist; consultation with a dietician, and consultation and assessment by a psychologist. The patients were followed up for at least 1 year after discharge or until death. Patient characteristics and clinical demographic data were compared between the two groups. Cox proportional hazards regression analysis was performed to calculate hazard ratios (HRs) for death or recurrent events of hospitalization in the HFDMP group in comparison with the non-HFDMP group while controlling for covariates. Results The two groups did not significantly differ in demographic characteristics. The risk of readmission was lower in the HFDMP group, but the difference was not statistically significant (HR = 0.36, p = 0.09). In patients with ischemic cardiomyopathy, the risk of readmission was significantly lower in the HFDMP group compared to the non-HFDMP group (HR = 0.13, p = 0.026). The total mortality rate did not have significant difference between this two groups. Conclusion The HFDMP may be beneficial for reducing recurrent events of heart failure hospitalization, especially in patients with ischemic cardiomyopathy. Trial registration Longitudinal case-control study ISRCTN98483065, 24/09/2019, retrospectively registered.

show abstract

Section: Discussionmentioning

confidence: 56%

Impact of multi-disciplinary treatment strategy on systolic heart failure outcome

Chen

Fang

Wang

et al. 2019

BMC Cardiovasc Disord

View full text Add to dashboard Cite

show abstract

“…A study conducted by Chen et al [ 13 ] revealed that heart failure management programs had a lower 1-year re-admission rate (29.67%) than patients who dealt with regular treatment (38.5%). In other countries of HF registries, such as the HF outcome registry in India, the 1-year re-admission rate was 30.1% [ 14 ], and in the Saudi Arabia registry, it was 36% [ 15 ]. On the other hand, in patients hospitalized with acute HF in Europe, the EHFS-2 registry shows a 1-year mortality rate of 21.9% [ 16 ].…”

Section: Discussionmentioning

confidence: 99%

Managing patients with heart failure: contemporary real-world experience

et al. 2022

View full text Add to dashboard Cite

Objective Heart failure (HF) is a chronic disease with growing numbers of patients and a significant compromise in quality of life and high mortality. The main purpose of this study was to evaluate the current practices in managing patients with HF among patients admitted to the hospital and discharged with a primary diagnosis of HF and patients managed in the heart function clinic. Results This study is a retrospective chart review of patients admitted to the hospital and discharged with a primary diagnosis of HF. A total of 448 patient charts were reviewed, of which 173 patients were in the hospital group and 275 patients in the Clinic group. 278 (62.1%) were men, and 170 (37.9%) were women. The Clinic group of patients were significantly received guideline-directed medical therapy (Beta-blockers, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Diuretics, Mineralocorticoid receptor antagonists—p < 0.001). The Clinic group of patients (17.1%) were significantly less re-hospitalized (p < 0.001) compared to the Hospital group (28%) at 180 days. Physician led multidisciplinary Heart function clinics have better adherence to guideline directed medical therapy and significantly lower rates of re-hospitalization thereby providing cost effective heart failure management with usual care.

show abstract

“…In the second study, researchers approached 197 patients with CHF soon after admission to King Abdullah Medical City in Jeddah, Kingdom of Saudi Arabia, non-randomly assigning 121 to a HFP and 76 to a usual care group. 25 Outcomes examined were length of index stay, in-house mortality, and one-year re-admission rate. The HFP consisted of a 4-day clinical pathway during hospitalization that involved careful monitoring and completion of a daily checklist by a nurse coordinator (which included patient education), a 72-hour post-discharge telephone call, and early post-discharge appointments with a cardiac nurse specialist and cardiologist.…”

Section: Discussionmentioning

confidence: 99%

Effects of a structured heart failure program on quality of life and frequency of hospital admission in Saudi Arabia

Alghalayini

Al‐Zaben

Sehlo

et al. 2019

SMJ

View full text Add to dashboard Cite

Objectives: To compare the quality of life (QOL) and frequency of hospital admission (FHA) in the past 4 months between congestive heart failure (CHF) patients involved in a structured heart failure program (HFP) compared with waitlisted controls. Methods: This study, employing an ex-post-facto comparative cross-sectional design, involved 80 patients with CHF (40 in the HFP and 40 controls). Those in the HFP had been enrolled for at least 4 months. Controls were waiting to be enrolled in the program. Participants completed a questionnaire assessing demographic, social/cultural, psychological, and CHF-related physical health characteristics, along with the primary dependent variables, QOL and FHA. Bivariate and multivariate analyses assessed differences between those in the HFP and controls. Results: Congestive heart failure patients in the HFP were significantly less likely than the control group to score below the median on heart failure-specific QOL, controlling for other variables (OR=0.83, 95% CI: 0.82-0.95, p =0.007). Those in the HFP were also significantly less likely than controls to be hospitalized within the past 4 months (OR=0.78, 95% CI: 0.69-0.88, p <0.001). Multivariate analyses indicated that CHF patients in the HFP were 95% less likely than controls to be admitted to the hospital during that period, independent of other risk factors for hospital admission. Conclusion: Involvement by patients with CHF in a structured HFP at King Abdulaziz University in Jeddah, Kingdom of Saudi Arabia, is associated with significantly higher quality of life and lower likelihood of being hospitalized compared to CHF patients not involved.

show abstract

Congestive heart failure disease management program: 1-Year population experience from a tertiary center heart failure registry in Saudi Arabia

Abstract: DMProg significantly decreased 1-year readmission rates, LOS, and in-house mortality.

Cited by 5 publications

References 15 publications

Impact of multi-disciplinary treatment strategy on systolic heart failure outcome

Impact of multi-disciplinary treatment strategy on systolic heart failure outcome

Managing patients with heart failure: contemporary real-world experience

Effects of a structured heart failure program on quality of life and frequency of hospital admission in Saudi Arabia

Contact Info

Product

Resources

About